Ionis Pharmaceuticals, Inc.
IONS
$55.39
-$0.63-1.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.31% | -7.97% | 16.39% | -9.94% | 9.95% |
| Total Receivables | 11.92% | 85.57% | -28.34% | 37.26% | 92.89% |
| Inventory | 499.38% | -51.69% | -19.69% | -63.20% | -70.47% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.15% | 301.22% | 10.07% | 36.26% | 18.77% |
| Total Current Assets | -3.33% | 21.41% | 14.13% | -7.18% | 10.64% |
|
|
|||||
| Total Current Assets | -3.33% | 21.41% | 14.13% | -7.18% | 10.64% |
| Net Property, Plant & Equipment | 40.16% | 43.96% | 41.19% | 40.98% | 13.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.50% | 27.47% | 38.42% | 43.48% | 40.32% |
| Total Assets | 0.31% | 22.65% | 17.32% | -1.56% | 10.92% |
|
|
|||||
| Total Accounts Payable | 109.23% | 49.12% | -34.64% | 58.26% | 146.67% |
| Total Accrued Expenses | 14.12% | 25.74% | 24.87% | -5.23% | -2.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -98.02% | 1,888.10% | 4,800.16% | 1,083.25% | 1,126.82% |
| Total Finance Division Other Current Liabilities | 17.04% | 4.08% | -3.23% | 15.59% | -19.46% |
| Total Other Current Liabilities | 17.04% | 4.08% | -3.23% | 15.59% | -19.46% |
| Total Current Liabilities | -64.82% | 186.30% | 152.67% | 196.64% | 193.06% |
|
|
|||||
| Total Current Liabilities | -64.82% | 186.30% | 152.67% | 196.64% | 193.06% |
| Long-Term Debt | 64.02% | 6.72% | 6.21% | -35.60% | -33.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 59.68% | 62.63% | 62.16% | 56.01% | -1.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -49.61% | -46.16% | -41.21% | -37.91% | -33.71% |
| Total Liabilities | 8.56% | 26.58% | 25.65% | -0.14% | -3.05% |
|
|
|||||
| Common Stock & APIC | 12.93% | 11.88% | 9.64% | 7.54% | 27.32% |
| Retained Earnings | -24.86% | -13.64% | -16.95% | -11.95% | -13.38% |
| Treasury Stock & Other | -21.12% | -7.16% | 17.95% | -7.47% | 19.67% |
| Total Common Equity | -30.39% | 3.30% | -16.87% | -6.72% | 139.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.39% | 3.30% | -16.87% | -6.72% | 139.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.39% | 3.30% | -16.87% | -6.72% | 139.56% |
|
|
|||||